Drug therapy for acute stroke.
Drug therapy for acute stroke will continue to evolve as major clinical trials are completed and compared. The efficacy of drug therapy discussed in this article focuses on preventing further thrombotic events through the use of anticoagulation and antithrombotic agents augmenting blood flow through recanalization and reperfusion therapies and protecting neurons damaged, but not destroyed using metabolic adjustment. As investigators provide information about how to alter chemical regimens to enhance recovery, it will be the primary responsibility of nursing to maintain vigilance and good judgment in keeping ourselves and the public informed about the therapeutic options available. We will need to further educate the public about the importance of early recognition of signs and symptoms. Stroke survivors and their families will depend upon us to keep them informed and involved, as will our professional colleagues. This article should provide updated knowledge about drug therapy that makes this possible.
Whitney
F
F
University of Wyoming, School of Nursing 82071-3065.
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006438:Hemodilution / Q000379:methods; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015424:Reperfusion / Q000379:methods; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors